Showing 63,501 - 63,520 results of 64,225 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (mean decrease)) ))', query time: 1.38s Refine Results
  1. 63501
  2. 63502
  3. 63503
  4. 63504
  5. 63505
  6. 63506
  7. 63507
  8. 63508
  9. 63509
  10. 63510
  11. 63511

    Disassembly and flattening of caveolae occur in the cardiomyocytes from SM22α KO mice. by Jun Wu (4002)

    Published 2022
    “…Data are presented as the mean ± SEM. **<i>P</i>< 0.01, ***<i>P</i>< 0.001 vs. WT control.…”
  12. 63512

    Dataset in. CSV. by Kare Chawicha Debessa (20660605)

    Published 2025
    “…</p><p>Conversely, reduced transparency in decision-making (AOR = 2.05; 95% CI: 1.39–3.00; p < 0.001) and insufficient advocacy (AOR = 3.01; 95% CI: 2.29–7.00; p = 0.011) were positively associated with dropout. …”
  13. 63513

    Elevated α-PheRS levels affect gut homeostasis, leading to additional progenitor cells, EEs, and differentiating EBs. by Manh Tin Ho (12481799)

    Published 2022
    “…<p>(A-C”’) Elevated α-PheRS or α-PheRS<sup>Cys</sup> levels induced by the esg<sup>ts</sup> system (see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010185#pgen.1010185.g001" target="_blank">Fig 1E</a> for details) led to additional YFP-positive cells and also to the accumulation of EEs <i>(</i>esg<sup>ts</sup><i>/+;UAS-α-PheRS</i><sup><i>(Cys)</i></sup><i>/+)</i>. …”
  14. 63514

    20E repressed HaP110 phosphorylation and expression. by Yu-Qin Di (8752317)

    Published 2021
    “…</b> 20E increased HaP110 dephosphorylation but decreased HaP110 expression in a dose and time dependent manner. …”
  15. 63515

    Image 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). A Bonferroni correction was applied.</p>Results<p>Among 118 participants (mean age 25.9; 44.1% self-identified as Black race), 545 visits were completed from 2019-2023. …”
  16. 63516

    Table 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). A Bonferroni correction was applied.</p>Results<p>Among 118 participants (mean age 25.9; 44.1% self-identified as Black race), 545 visits were completed from 2019-2023. …”
  17. 63517

    Image 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). A Bonferroni correction was applied.</p>Results<p>Among 118 participants (mean age 25.9; 44.1% self-identified as Black race), 545 visits were completed from 2019-2023. …”
  18. 63518

    Image 11_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). A Bonferroni correction was applied.</p>Results<p>Among 118 participants (mean age 25.9; 44.1% self-identified as Black race), 545 visits were completed from 2019-2023. …”
  19. 63519

    Image 7_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). A Bonferroni correction was applied.</p>Results<p>Among 118 participants (mean age 25.9; 44.1% self-identified as Black race), 545 visits were completed from 2019-2023. …”
  20. 63520

    Image 8_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Multivariable linear mixed effects models estimated association between HC and immune markers (Primary outcome: proportion of CD4+ T cells expressing CCR5; Secondary outcomes: other immune markers, in vitro HIV enhancement). A Bonferroni correction was applied.</p>Results<p>Among 118 participants (mean age 25.9; 44.1% self-identified as Black race), 545 visits were completed from 2019-2023. …”